Drug Profile
Research programme: ATP-binding cassette transporter activators for metabolic disorders - Limerick BioPharma
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Limerick BioPharma
- Class Small molecules
- Mechanism of Action ATP-binding cassette transporter stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Metabolic disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Metabolic-disorders in USA